Acceptability of Depo-subQ Provera 104 in Uniject vs. Intramuscular Depo-Provera Among HIV+ Women & Providers, Uganda
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess acceptability and side effects of a low-dose
injectable contraceptive formulation which is delivered under the skin (subcutaneously), as
compared with injectable contraception delivered into the muscle (intramuscularly) among
adult HIV-positive women who attend mobile clinics for HIV care and wish to use injectable
contraception. The investigators will also assess experiences experiences delivering these
two types of injections among health care providers working within the HIV care clinics.
Phase:
N/A
Details
Lead Sponsor:
Johns Hopkins Bloomberg School of Public Health
Collaborators:
Bill and Melinda Gates Foundation Rakai Health Sciences Program Society of Family Planning